April 7, 2026 — Greenland Energy (NASDAQ: GLND),an energy exploration company focused on developing hydrocarbon resources in Greenland’s Jameson Land Basin, marked its visit to the Nasdaq MarketSite in Times Square with a ceremonial Opening Bell ringing. CEO Robert Price, Executive Chairman Larry G.
April 7, 2026 — Eco Wave Power (NASDAQ: WAVE), a global leader in onshore wave energy technology, reported that its EWP-EDF One pilot project at Jaffa Port in Israel generated more than 1,200 kWh of renewable electricity during March 2026, with approximately six days of moderate wave conditions ranging from 1 to 2 meters. The results highlight the system’s ability to efficiently convert commonly occurring sea states into power, reinforcing its potential as a reliable energy solution for coastal infrastructure and AI-driven data center demand while continuing to demonstrate stable, zero-downtime operations since early 2025.
April 7, 2026 — Researchers at the University of Calgary in Canada are conducting further trials after early studies revealed that vitamin B3, or niacin, holds promise in restoring immune function in the fight against glioblastoma, a brain cancer that grows aggressively and is hard to treat. It remains to be seen whether clinical studies involving larger numbers of patients confirm what these early studies have shown about the benefits of using niacin alongside radiotherapy and chemotherapy to boost treatment outcomes.
April 7, 2026 — Civil defense authorities in Israel have been working to improve the alert system depended upon to get people into shelters before incoming projectiles hit. AI is playing a key role in improving that alert system.
April 7, 2026 — Artificial intelligence is quickly changing the way investment banking works, and while this shift brings clear benefits, it is also creating new challenges. One of the biggest concerns today is the growing skills gap among junior bankers as AI takes over many of their traditional responsibilities.
April 7, 2026 — Australia has approved new legislation that brings crypto businesses under the country’s formal financial services regime. The measure, introduced by the Treasury last November, passed both chambers of parliament, setting clear requirements for companies dealing in digital assets.
April 7, 2026 — The U. S.
April 7, 2026 — Chinese electric vehicles remain locked out of the American market, but the appetite for them keeps growing. Tariffs introduced under the Biden administration pushed duties past 100%, sealing the border to Chinese EVs.
April 7, 2026 — A water treatment facility in Japan is exploring a novel form of renewable energy by tapping into the natural process of osmosis. This process, where water moves from a less concentrated solution to a more concentrated one, has long been understood.
April 7, 2026 — AINewsWire Editorial Coverage: As regulatory expectations intensify and manufacturing complexity grows, pharmaceutical companies are moving beyond traditional quality systems toward a new paradigm: embedding artificial intelligence (“AI”) directly into operations as a real-time compliance layer. Rather than relying on retrospective audits and manual oversight, AI-driven systems now continuously monitor, validate and optimize production processes to align with evolving Good Manufacturing Practice (“GMP”) standards.
April 7, 2026 — Renewable energy capacity expanded by nearly 700 gigawatts last year as geopolitical turbulence continued to make the case for accelerating the transition to clean energy. With Middle East tensions continuing to rattle fossil fuel markets, nations are increasingly treating clean energy as a strategic shield against supply disruptions, not just a climate commitment.
April 7, 2026 — TransCode Therapeutics (NASDAQ: RNAZ), a clinical-stage company focused on immuno-oncology and RNA-based therapies, announced that it has entered into a financing agreement with an institutional healthcare investor for up to $20 million. The arrangement includes up to $6 million in pre-paid advances and a three-year Standby Equity Purchase Agreement allowing the company to sell up to $14 million in common stock, providing financial flexibility to support its Phase 2a trial of lead candidate TTX-MC138 and ongoing operations.
April 7, 2026 — NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage company developing broad-spectrum antivirals, announced it has filed an application with the U.
April 7, 2026 — AINewsWire Editorial Coverage: Pharmaceutical manufacturing is undergoing a structural shift as regulators demand higher standards for contamination control, data integrity and operational traceability. The European Union’s revised GMP Annex 1 emphasizes minimizing human intervention and implementing a comprehensive contamination control strategy, requiring manufacturers to assess and mitigate contamination risks across personnel, processes and environments.
April 7, 2026 — Versus Systems (NASDAQ: VS), a leading provider of gamification and audience engagement technology, has engaged IBN to support its corporate communications strategy. Through the partnership, IBN will leverage its expansive investor-focused distribution network to increase awareness of Versus Systems, whose platform enables interactive audience participation and real-world rewards across digital and live environments, serving brands, sports leagues and entertainment partners globally.
April 7, 2026 — Micropolis AI Robotics (NYSE American: MCRP), a pioneer in unmanned ground vehicles and AI-driven autonomous mobility solutions, announced that Founder and CEO Fareed Aljawhari will participate in a fireside chat at Maxim Group’s AI Infrastructure Virtual Conference, “Powering the AI Revolution – Building the Infrastructure Behind Generative AI,” taking place today, April 7, 2026, at 4:00 p. m.
April 7, 2026 — Megan Holdings (NASDAQ: MGN), a Malaysia-based company focused on the development, construction and maintenance of aquaculture farms, announced the closing of its follow-on public offering of 20,750,000 Class A ordinary shares at a public offering price of $0. 40 per share, generating gross proceeds of approximately $8.
April 7, 2026 — Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, announced that the European Patent Office has issued a Rule 71(3) communication indicating its intent to grant a patent covering methods of preventing stress-induced fear and depressive-like behavior using serotonin 4 (5-HT4) receptor agonists. The patent, exclusively licensed from Columbia University, is expected to strengthen the company’s intellectual property position across major European markets as Silo advances its pipeline targeting stress-related and central nervous system disorders.
April 7, 2026 — A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ), a global leader in smart retail technology, announced that it has received formal notice from The Nasdaq Stock Market LLC that the company has regained compliance with the annual meeting requirement for continued listing under Nasdaq Listing Rule 5620.
April 7, 2026 — This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.